Income statement, balance sheet and cash flow statement for the last 4 fiscal years, taken from the XBRL data OneMedNet Corp files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2022
FY2023
FY2024
FY2025
Revenue
1.15
1.02
0.64
1.36
Cost of revenue
1.51
1.15
0.92
1.86
Gross profit
-0.36
-0.13
-0.28
-0.5
Research and development
1.59
2.07
1.47
1.52
Selling and marketing
0.96
1.12
0.83
1.27
General and administrative
4.81
3.54
7.03
6.38
Operating expenses
7.36
6.72
9.32
9.16
Operating income
-7.72
-6.85
-9.61
-9.67
Interest expense
0.4
0.01
0.15
0.07
Other non-operating income
-22.7
-26.9
-0.52
6.87
Pre-tax income
-30.4
-33.8
-10.1
-2.8
Income tax
0.02
0.02
0
0
Income from continuing operations
-10.1
-2.8
Net income
-30.5
-33.8
-10.1
-2.8
EBITDA
-7.69
-6.83
-9.55
-9.6
EPS, basic
-7.66
-4.65
-0.36
-0.06
EPS, diluted
-7.66
-4.65
-0.36
-0.06
Shares, basic (weighted)
3.97
7.27
28.1
44.5
Shares, diluted (weighted)
3.97
7.27
28.1
44.5
Balance sheet
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
0.27
0.05
0.17
0.59
Receivables
0.02
0.15
0.21
0.5
Other current assets
0.1
0.17
0.39
0.51
Total current assets
0.39
0.37
3.62
2.1
Property, plant and equipment
0.08
0.1
0.11
0.06
Total assets
1.29
0.46
3.73
2.15
Accounts payable
1.18
4.68
6.04
3.2
Accrued liabilities
1.68
Deferred revenue
0.18
0.25
0.56
0.39
Short-term debt
0.47
9.38
0.97
Total current liabilities
26.1
13.8
19.2
4.83
Other non-current liabilities
0.04
0.07
0.45
Total liabilities
27.6
13.9
19.7
5.12
Total debt
0.47
2.32
0.22
Paid-in capital
13.7
78
86.1
102
Retained earnings
-57.7
-91.4
-102
-104
Treasury stock
-0.53
-0.53
Shareholders' equity
-26.4
-13.4
-16
-2.97
Total equity
-26.4
-13.4
-16
-2.97
Total liabilities and equity
1.29
0.46
3.73
2.15
Shares outstanding
4.03
23.6
28
51.8
Cash flow statement
FY2022
FY2023
FY2024
FY2025
Net income
0.34
-33.8
-10.1
-2.8
Depreciation and amortization
0.03
0.03
0.06
0.07
Stock-based compensation
1.87
1.48
0.63
2.03
Change in receivables
0.07
-0.13
-0.06
-0.28
Change in payables
0.42
0.72
1.21
0.37
Cash from operations
-4.7
-4.79
-6.95
-7.5
Capital expenditures
-0.06
-0.04
-0.05
-0.01
Cash from investing
-0.06
-0.04
-1.98
2.31
Debt repaid
-0.2
Stock issued
0.01
Cash from financing
4.33
4.61
9.06
5.61
Net change in cash
-0.43
-0.22
0.13
0.41
Free cash flow
-4.76
-4.84
-7
-7.52
Interest paid
0.03
0.02
Income taxes paid
0.02
0
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $0.65 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
-67.6%
Gross profit / revenue.
Operating margin
-700.6%
Operating income / revenue.
Net margin
-584.6%
Net income / revenue.
FCF margin
-473.7%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-472.6%
Cash from operations / revenue.
Return on assets (ROA)
-623.6%
Net income / average total assets.
R&D / revenue
96.3%
Research and development expense / revenue.
Stock-based pay / revenue
173.3%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
1.1%
Capital expenditures / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
111.4%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
5.6%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y
-42.3%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
18.6%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Share count change, 1y
58.7%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
123.8%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.28x
Current assets / current liabilities.
Quick ratio
0.22x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.08x
(Cash + short-term investments) / current liabilities.
Debt / assets
9.7%
Total debt / total assets.
Liabilities / assets
357.9%
Total liabilities / total assets.
Net debt
-$226.0K
Total debt - cash - short-term investments. Negative means more cash than debt.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$0.03
Revenue / diluted weighted shares.
FCF per share
-$0.12
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.12
Cash from operations / diluted weighted shares.
Book value per share
-$0.06
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
26.5x
Market cap / revenue.
EV/Sales
26.3x
Enterprise value / revenue.
FCF yield
-17.9%
Free cash flow / market cap.
Earnings yield
-22.1%
Net income / market cap (the inverse of P/E).
What was OneMedNet Corp's revenue in fiscal 2025?
OneMedNet Corp reported revenue of $1.4M for fiscal 2025, 111.4% higher than the year before.
Was OneMedNet Corp profitable in fiscal 2025?
No. It reported a net loss of $2.8M.
How much free cash flow did OneMedNet Corp generate in fiscal 2025?
Cash from operations of $7.5M minus capital expenditures of $13.0K left free cash flow of -$7.5M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.